Skip to main content

Table 2 Laboratory data and blood gas sampling data at the start of CKRT and at 24 h

From: Dose of nafamostat mesylate during continuous kidney replacement therapy in critically ill patients: a two-centre observational study

 

Baseline

24 h

Albumin, g/dL

2.6 ± 0.7

2.5 ± 0.6

Haemoglobin, g/dL

9.8 ± 2.4

9.2 ± 1.8

Platelet, ×103/µl

142 ± 113

112 ± 88

PT-INR

  

 < 1.5

205 (76.2%)

206 (77.2%)

 > 1.5

64 (23.8%)

61 (22.8%)

APTT sec

  

 < 40

170 (64.6%)

111 (41.4%)

 40–80

87 (33.1%)

139 (51.9%)

 > 80

6 (2.3%)

18 (6.7%)

Serum creatinine, mg/dL

4.58 ± 3.65

3.33 ± 2.67

Calcium, mg/dL

7.9 ± 1.1

8.3 ± 1.0

Magnesium, mg/dL

2.3 ± 0.6

2.2 ± 0.6

Inorganic phosphate, mg/dL

5.4 ± 2.6

4.1 ± 1.8

White blood cell,×103/µl

  

 < 3

13 (4.9%)

18 (6.8%)

 3–9

81 (30.5%)

86 (32.3%)

 > 9

172 (64.7%)

162 (60.9%)

C-reactive protein, mg/dL

9.3 ± 10.3

10.7 ± 10.8

FiO2

0.37 ± 0.21

0.34 ± 0.14

pH

7.33 ± 0.11

7.37 ± 0.39

PaO2, mmHg

111.0 ± 63

93.8 ± 34

PaCO2, mmHg

35.3 ± 10.4

37.2 ± 9.1

Bicarbonate, mmol/L

18.5 ± 5.6

22.0 ± 4.3

Sodium, mmol/L

137.0 ± 7.3

137.3 ± 4.6

Potassium, mmol/L

4.8 ± 1.0

4.3 ± 0.7

Chloride, mmol/L

106.6 ± 7.6

106.8 ± 4.5

Lactate, mmol/L

3.7 ± 5.9

2.8 ± 3.6

  1. Values are presented as means with standard deviations, otherwise specified
  2. CKRT denotes continuous kidney replacement therapy; PT-INR, prothrombin time international normalised ratio; APTT, activated partial thromboplastin time; FiO2, fraction of inspiratory oxygen; PaO2, partial pressure of arterial oxygen; PaCO2, partial pressure of arterial carbon dioxide